About the Authors

Guillermo Horga

guillermo.horga@gmail.com

Affiliations Department of Psychiatry, New York State Psychiatric Institute, Columbia University Medical Center, New York, New York, United States of America, Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain, Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain

Emilio Fernández-Egea

Affiliations Department of Psychiatry, University of Cambridge, Cambridge, and the Cambridgeshire and Peterborough NHS Foundation Trust, Huntingdon, United Kingdom, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain

Anna Mané

Affiliations Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain, Centre Forum, Barcelona, Spain

Mireia Font

Affiliation Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain

Kelly C. Schatz

Affiliation Department of Psychiatry, New York State Psychiatric Institute, Columbia University Medical Center, New York, New York, United States of America

Carles Falcon

Affiliation GIB-UB. CIBER-BBN, Barcelona, Spain

Francisco Lomeña

Affiliations Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain, Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

Miguel Bernardo

Affiliations Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain, Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain, Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

Eduard Parellada

Affiliations Schizophrenia Unit, Neuroscience Institute, Hospital Clinic of Barcelona, Barcelona, Spain, Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain, Institut d′Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

Competing Interests

Dr. Parellada declares having received grant support and lecture fees from Janssen- Cilag and GlaxoSmithKline, and grant support from Lilly. Dr. Lomeña±a declares having received lecture fees from GE Healthcare. Dr. Font declares having received grant support from Maraton TV3 and Janssen-Cilag and travel support from Janssen-Cilag. Dr. Bernardo declares having received grant support from Bristol-Myers Squibb, CIBERSAM, Eli Lilly, FIS-Institute of Health Carlos III, the Government of Catalonia, Janssen-Cilag, Marató TV3, Organon and Pfizer, and declares board membership with and lecture fees from Bristol-Myers Squibb, Eli Lilly, Janssen-Cilag, Mylan and Pfizer. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: GH EP FL EF-E MF MB. Performed the experiments: GH AM EF-E MF. Analyzed the data: GH AM KS CF. Wrote the paper: GH.